Skip to main content
Fig. 1 | BMC Rheumatology

Fig. 1

From: Methotrexate therapy impacts on red cell distribution width and its predictive value for cardiovascular events in patients with rheumatoid arthritis

Fig. 1

Differences in RDW levels in patients with CV events and with/without MTX; a RDW at last follow up in all RA patients notwithstanding concomitant treatment, depending on CV-events (yes: n = 23, no: n = 362). b RDW in all patients independent of CV events, depending on MTX-treatment (yes: n = 222, no: n = 163). c RDW in patients with and without MTX intake conditional to CV events. (MTX yes+CV yes: n = 15, MTX yes+CV no: n = 207, MTX no+CV yes: n = 8, MTX no+CV no: n = 155), n.s. not significant at p-level 0,05, *: p = 0,006 as determined by Mann Whitney U test

Back to article page